Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
or

Olema Pharmaceuticals Inc (OLMA)

Olema Pharmaceuticals Inc (OLMA)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
3.33 -0.01 (-0.30%) 04/02/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 3.48 +0.15 (+4.50%) 17:57 ET
Quote Overview for Wed, Apr 2nd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
3.28
Day High
3.63
Open 3.30
Previous Close 3.34 3.34
Volume 2,202,300 2,202,300
Avg Vol 1,012,525 1,012,525
Stochastic %K 5.27% 5.27%
Weighted Alpha -71.12 -71.12
5-Day Change -0.81 (-19.57%) -0.81 (-19.57%)
52-Week Range 3.28 - 16.62 3.28 - 16.62
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 228,232
  • Shares Outstanding, K 68,333
  • Annual Sales, $ 0 K
  • Annual Income, $ -129,470 K
  • EBIT $ -142 M
  • EBITDA $ -142 M
  • 60-Month Beta 2.10
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.53

Options Overview Details

View History
  • Implied Volatility 370.56% ( -175.05%)
  • Historical Volatility 56.71%
  • IV Percentile 98%
  • IV Rank 65.83%
  • IV High 545.61% on 04/01/25
  • IV Low 33.34% on 09/12/24
  • Put/Call Vol Ratio 999.99
  • Today's Volume 20
  • Volume Avg (30-Day) 142
  • Put/Call OI Ratio 0.34
  • Today's Open Interest 1,942
  • Open Int (30-Day) 2,834

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.51
  • Number of Estimates 4
  • High Estimate -0.42
  • Low Estimate -0.59
  • Prior Year -0.56
  • Growth Rate Est. (year over year) +8.93%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.28 +1.52%
on 04/02/25
Period Open: 4.37
4.75 -29.89%
on 03/19/25
-1.04 (-23.80%)
since 02/28/25
3-Month
3.28 +1.52%
on 04/02/25
Period Open: 5.57
6.70 -50.31%
on 02/05/25
-2.24 (-40.22%)
since 01/02/25
52-Week
3.28 +1.52%
on 04/02/25
Period Open: 10.84
16.62 -79.96%
on 08/01/24
-7.51 (-69.28%)
since 04/02/24

Most Recent Stories

More News

Business Summary

Olema Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It engages in discovery, development and commercialization of therapies for women's cancers. The company's product pipeline includes OP-1250, which is in clinical stage. Olema Pharmaceuticals Inc. is based in San Francisco, California....

See More

Key Turning Points

3rd Resistance Point 3.90
2nd Resistance Point 3.76
1st Resistance Point 3.55
Last Price 3.33
1st Support Level 3.20
2nd Support Level 3.06
3rd Support Level 2.85

See More

52-Week High 16.62
Fibonacci 61.8% 11.52
Fibonacci 50% 9.95
Fibonacci 38.2% 8.38
Last Price 3.33
52-Week Low 3.28

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trader's Cheat Sheet: Your Secret Weapon for Smarter Trades